Certain treatments for୵ltiple sclerosisS) נspecifically, anti-CD20 antibody therapies andǩlenyaਦingolimod) נare likely to reduce the..
Study: Anti-CD20 Treatments, Gilenya Lower Effectiveness of COVID-19 Vaccines

Software
multiple sclerosis
http://disorders.solutions/multiple-sclerosis/study-anticd20-treatments-gilenya-lower-effectiveness-of-covid19-vaccines